Akshaya Agribiomed Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 30-12-2024
- Paid Up Capital ₹ 3.40 M
as on 30-12-2024
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.90 Cr
as on 30-12-2024
- Revenue 26.17%
(FY 2022)
- Profit 8.22%
(FY 2022)
- Ebitda -112.42%
(FY 2022)
- Net Worth -9.44%
(FY 2022)
- Total Assets 3.91%
(FY 2022)
About Akshaya Agribiomed
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.40 M.
The company has closed loans amounting to ₹2.90 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Gudipati Reddy, Gudipati Reddy, Omprakash Tautam, and One other member serve as directors at the Company.
- CIN/LLPIN
U33110TG2011PTC075308
- Company No.
075308
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jul 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Akshaya Agribiomed?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gudipati Reddy  | Director | 13-Jul-2022 | Current |
| Gudipati Reddy | Director | 01-Jul-2011 | Current |
| Omprakash Tautam | Director | 22-Apr-2019 | Current |
| Sanit Gudipati | Director | 30-May-2022 | Current |
Financial Performance of Akshaya Agribiomed.
Akshaya Agribiomed Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.17% increase. The company also saw a slight improvement in profitability, with a 8.22% increase in profit. The company's net worth dipped by a decrease of 9.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akshaya Agribiomed?
Unlock access to Akshaya Agribiomed's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Sep 2017 | ₹2.26 Cr | Satisfied |
State Bank Of Hyderabad Creation Date: 21 Aug 2012 | ₹6.40 M | Satisfied |
How Many Employees Work at Akshaya Agribiomed?
Unlock and access historical data on people associated with Akshaya Agribiomed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akshaya Agribiomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akshaya Agribiomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
